Genetic disruption of the oncogenic HMGA2–PLAG1–IGF2 pathway causes fetal growth restriction

MLA

Yves Le Bouc, et al. “Genetic Disruption of the Oncogenic HMGA2–PLAG1–IGF2 Pathway Causes Fetal Growth Restriction.” Genetics in Medicine, vol. 20, Feb. 2018, pp. 250–58. EBSCOhost, https://doi.org/10.1038/gim.2017.105.

APA

Yves Le Bouc, Frédéric Brioude, Tony Yuen, Walid Abi Habib, James T. Bennett, Madeleine D. Harbison, Thomas Edouard, Jennifer Salem, Frédérique Tixier, Anne Lienhardt-Roussie, Salah Azzi, & Irène Netchine. (2018). Genetic disruption of the oncogenic HMGA2–PLAG1–IGF2 pathway causes fetal growth restriction. Genetics in Medicine, 20, 250–258. https://doi.org/10.1038/gim.2017.105

Chicago

Yves Le Bouc, Frédéric Brioude, Tony Yuen, Walid Abi Habib, James T. Bennett, Madeleine D. Harbison, Thomas Edouard, et al. 2018. “Genetic Disruption of the Oncogenic HMGA2–PLAG1–IGF2 Pathway Causes Fetal Growth Restriction.” Genetics in Medicine 20 (February): 250–58. doi:10.1038/gim.2017.105.